40.660
40.66 (0%)
As of Dec 20, 2024
Kymera Therapeutics, Inc. [KYMR]
Source:
Company Overview
Kymera Therapeutics, Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.
Country | United States |
Headquarters | watertown, massachusetts |
Phone Number | 857-285-5314 |
Industry | |
CEO | Nello Mainolfi |
Website | www.clinicaltrials.gov |